CLINICAL RESEARCH: CARDIAC IMAGING
Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance
Carlos J. Soriano, MD*,
Francisco Ridocci, MD, PhD, FESC*,*,
Jordi Estornell, MD ,
Javier Jimenez, MD*,
Vicente Martinez, MD, PhD and
José A. De Velasco, MD, PhD*
* Servicio de Cardiología, Consorcio Hospital General Universitario de Valencia
Unidad de TC y RM, ERESA, Valencia, Spain
Manuscript received July 13, 2004;
revised manuscript received October 24, 2004,
accepted November 1, 2004.
* Reprint requests and correspondence: Dr. Francisco Ridocci, Servicio de Cardiología, Hospital General Universitario, Avda. Tres Cruces 2a, 46014 Valencia, Spain
(Email: ridocci_fra{at}gva.es).
OBJECTIVES: We evaluated the feasibility of using late gadolinium-enhanced (LGE) cardiovascular magnetic resonance (CMR) to distinguish left ventricular (LV) systolic dysfunction related or not to coronary artery disease (CAD) in patients with heart failure (HF) but without clinical suspicion of CAD as the underlying cause.
BACKGROUND: In patients with known CAD, LGE-CMR is capable of distinguishing LV systolic dysfunction related to CAD from dilated cardiomyopathy.
METHODS: Seventy-one patients with HF and LV systolic dysfunction, without a previous history of myocardial infarction, with neither Q waves nor clinical data suggesting CAD, underwent both LGE-CMR and coronary angiography.
RESULTS: Twenty-six patients (37%) had angiographically proven CAD ( 70% stenosis of a major epicardial vessel) (angio [+] group), and 45 (63%) had unobstructed coronary arteries (angio [] group). Twenty-one patients in the angio (+) group (21 of 26, 81%) showed subendocardial and/or transmural enhancement, whereas only 4 (9%) of 45 in the angio () group showed it (p < 0.001). In 7 patients (7 of 71, 10%), we found a different pattern of mid-wall enhancementnamely, 3 of 26 patients in the angio (+) group and 4 of 45 in the angio () group (11% vs. 9%, p = 0.7). Mid-wall enhancement in the angio (+) group was distributed in segments other than those which had subendocardial enhancement.
CONCLUSIONS: In patients with HF and LV systolic dysfunction without clinical suspicion of CAD, LGE-CMR is an excellent tool for classifying patients in relation to the presence or absence of underlying CAD. Thus, CMR might offer a valid alternative to coronary angiography for the detection of CAD in these patients.
|
Abbreviations and Acronyms
| | CAD = coronary artery disease | | CMR = cardiovascular magnetic resonance | | ECG = electrocardiographic | | HF = heart failure | | LGE = late gadolinium enhancement/enhanced | | LV = left ventricle/ventricular | | MI = myocardial infarction |
|
This article has been cited by other articles:

|
 |

|
 |
 
J.-B. le Polain de Waroux, A.-C. Pouleur, C. Goffinet, A. Pasquet, J.-L. Vanoverschelde, and B. L. Gerber
Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging
Eur. Heart J.,
October 2, 2008;
29(20):
2544 - 2551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U Sechtem, H Mahrholdt, and H Vogelsberg
Cardiac magnetic resonance in myocardial disease
Heart,
December 1, 2007;
93(12):
1520 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G Assomull, D. J Pennell, and S. K Prasad
Cardiovascular magnetic resonance in the evaluation of heart failure
Heart,
August 1, 2007;
93(8):
985 - 992.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
184 - 202.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ridocci, C. J. Soriano, and J. Estornell
Imaging approach to the assessment of cardiomyopathies using delayed enhancement cardiovascular magnetic resonance
Eur. Heart J.,
December 1, 2005;
26(23):
2601 - 2602.
[Full Text]
[PDF]
|
 |
|
|